Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients.

scientific article

Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1537-2995.1988.28588337325.X
P698PubMed publication ID3420667

P50authorGines EscolarQ53538447
P2093author name stringR Castillo
M Garrido
A Ordinas
R Mazzara
P433issue5
P921main subjectthrombocytopeniaQ585285
P304page(s)406-411
P577publication date1988-09-01
P1433published inTransfusionQ15758500
P1476titleExperimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients
P478volume28

Reverse relations

cites work (P2860)
Q33376798A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation
Q43700338Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss
Q41573535Changes in platelet function following cold storage of RBC suspensions
Q36862718Clinical Transfusion Medicine
Q33433620Cryopreserved platelet concentrate transfusions in 43 dogs: a retrospective study (2007-2013).
Q35856151Current status of transfusion triggers for red blood cell concentrates
Q33345596Effects of plasma substitutes on hemostasis
Q33497609Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions
Q50563846Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology.
Q37059222Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates
Q53563730Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
Q83968093Massive transfusion and coagulopathy: pathophysiology and implications for clinical management
Q52321360Mathematical bottom-line of intraoperative haemodilution.
Q42121272Mécanismes et traitement de l’anémie aiguë chez le brûlé grave
Q33376755Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins
Q33497317Procoagulant effect of incompatible platelet transfusions in alloimmunized refractory patients
Q34492729Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period
Q34988663Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period
Q35106170Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period
Q37209117Recommendations for the transfusion of plasma and platelets
Q37119693Recommendations for the transfusion of red blood cells
Q37178943Red blood cell transfusion triggers in acute leukemia: a randomized pilot study
Q50227235Red blood cell transfusion: 2016 clinical practice guidelines from AABB.
Q36867301Role of red blood cell flow behavior in hemodynamics and hemostasis
Q33403558Use of fresh platelet concentrate or lyophilized platelets in thrombocytopenic dogs with clinical signs of hemorrhage: a preliminary trial in 37 dogs
Q77627784[Benefits and risks of scheduled autologous transfusion]
Q64892820[Colloids and perioperative hemostasis: don't forget the context, please!].
Q79345654[Prerequisites of a functional haemostasis. What must be considered at the scene of an accident, in the emergency room and during an operation?]

Search more.